HPV testing in patient management: Atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion

Emerging Issues on HPV Infections: From Science to Practice

Volumn , Issue , 2006, Pages 120-139

  Cox, J Thomas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951714466     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000092742     Document Type: Chapter

References (69)

1. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV.: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
2. Bosch FX, Lorincz A, Munoz N, Meijer CJLM, Shah KV.: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-265.
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N.: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:1-3.
4. Nobbenhuis M, Walboomers JM, Helmerhorst TJ, Rozendaal L, et al.: Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999;354:20.
5. Jacobs MV, Zielinski D, Meijer CJ, Pol RP, Voorhorst FJ, de Schipper FA, Runsink AP, Snijders PJ, Walboomers JM.: A simplified and reliable HPV testing or archival Papanicolaou-stained cervical smears: application to cervical smears from cancer. Br J Cancer 2000;82:1421-1426.
6. Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG, Rush BB, Schussler JE, Schiffman M.: A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 2002;94:1406-1414.
7. Solomon D, Schiffman MH, Tarone R.: Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-299.
8. National Cancer Institute Workshop: The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnosis. JAMA 1989;262:931-934.
9. The Bethesda system for reporting cervical/vaginal cytologic diagnoses. Report of the 1991 Bethesda Workshop. Am J Surg Pathol 1992;16:914-916.
10. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright TC, Young N, The Forum Group Members, The Bethesda 2001 Workshop: The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119.
11. Selvaggi SM.: Reporting of atypical squamous cells cannot exclude a high-grade squamous intraepithelial lesion (ASC-H) on cervical samples: is it significant? Diagn Cytopathol 2003;29:38-41.
12. Kinney WK, Manos MM, Hurley LB, Ransley JE.: Where's the high grade cervical neoplasia? The importance of the minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 1998;91:973-976.
13. Raffle AE, Alden B, MacKenzie EFD.: Detection rates for abnormal cervical smears: what are we screening for? Lancet 1995;345:1469-1473.
14. ASCUS-LSIL Triage Study (ALTS) Group: Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-1392.
15. ASCUS-LSIL Triage Study (ALTS) Group: A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188: 1393-1400.
16. Stoler MH, Schiffman M.: Toward optimal laboratory use. Interobserver reproducibility of cervical cytology and histologic interpretations. Realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001;285:1500-1505.
17. Renshaw AA, Davey DD, Birdsong GG, Walsh M, Styer PE, Mody DR, Solomon D.: Precision in gynecologic cytologic interpretation: a study from the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 2003;127:1413-1420.
18. Scott DR, Hagmar B, Maddox P, Hjerpe A, Dillner J, Cuzick J, Sherman ME, Stoler MH, Kurman RJ, Kiviat NB, Manos MM, Schiffman M.: Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom. Cancer 2002;96:14-20.
19. Confortini M, Carozzi F, Dalla Palma P, Ghiringhello B, Parisio F, Prandi S, Ronco G, Ciatto S, Montanari G, GISCI Working Group for Cervical Cytology: Interlaboratory reproducibility of atypical squamous cells of undetermined significance report: a national survey. Cytopathology 2003;14:263-268.
20. Cox JT.: Management of women with cervical cytology interpreted as ASC-US or ASC-H. Clin Obstet Gynecol 2005;48:160-170.
21. Scheiden R, Wagener C, Knolle U, Dippel W, Capesius C.: Atypical squamous cells of undetermined significance: audit and the impact of potential litigation. Retrospective review of 682 cases. Cytopathology 2003;14:257-262.
22. Bergeron C, Jeannel D, Poveda J, Cassonet P, Orth G.: Human papillomavirus testing in women with mild cytologic atypia. Obstet Gynecol 2000;95:821-827.
23. Sherman ME, Schiffman M, Cox JT.: Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 2002;94:102-107.
24. Flynn K, Rimm DL.: Diagnosis of ASCUS in women over age 50 is less likely to be due to dysplasia. Diagn Cytopathol 2001;24:132-136.
25. Sherman ME, Solomon D, Schiffman M, for the ALTS Group: Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. Am J Clin Pathol 2001;116:386-394.
26. Alli PM, Ali SZ.: Atypical squamous cells of undetermined significance rule out high-grade squamous intraepithelial lesion: cytopathologic characteristics and clinical correlates. Diagn Cytopathol 2003;28:308-312.
27. Louro AP, Roberson J, Eltoum I, Chhieng DC.: Atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion. A follow-up study of conventional and liquid-based preparations in a high-risk population. Am J Clin Pathol 2003;120:392-397.
28. Cox JT, Schiffman M, Solomon D, ASCUS-LSIL Triage Study (ALTS) Group: Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 2003;188:1406-1412.
29. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Kurman RJ.: HPV testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of ASCUS. Am J Obstet Gynecol 1995;172:946-954.
30. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA.: Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;281:1605-1610.
31. Wright TC, Lorincz AT, Ferris DG, Richart RM, Ferenczy A, Mielzynska I, Borgatta L.: Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Pap smears. Am J Obstet Gynecol 1998;178:962-966.
32. Guido R, Schiffman M, Solomon D, Burke L, ASCUS LSIL Triage Study (ALTS) Group: Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol 2003;188:1401-1405.
33. Sherman ME, Wang SS, Wheeler CM, Rich L, Gravitt PE, Tarone R, Schiffman M.: Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions. Cancer Epidemiol Biomarkers Prev 2003;12: 1038-1044.
34. Arbyn M, Buntinx F, Van Ranst M, Paraskevides E, Martin-Hirsch P, Dillner J.: Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004;96:280-293.
35. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ, ASCCP-Sponsored Consensus Conference: 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129.
36. ACOG Practice Bulletin. Management of abnormal cervical cytology and histology. Clinical management guidelines for the Obstetrician and Gynecologist, 2005, vol 66.
37. Wright TC, Sun XW, Koulos J.: Comparison of management algorithms for the evaluation of women with low grade cytologic abnormalities. Obstet Gynecol 1995;85:202-210.
38. Ferris DG, Wright TC, Litaker MS, Richart RM, Lorincz AT, Sun SW.: Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV testing or colposcopy? J Fam Pract 1998;46:125-134.
39. Ferris DG, Wright TC, Litaker MS, Richart RM, Lorincz AT, Sun SW.: Comparison of two tests for detection carcinogenic HPV in women with Papanicolaou smear reports of ASCUS or LSIL. J Fam Pract 1998;46:136-141.
40. Shlay JC, Dunn T, Byers T, Baron AE, Douglas J.: Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on Papanicolaou smears. Obstet Gynecol 2000;96:410-416.
41. Goff BA, Muntz HG, Bell DA, Wertheim I, Rice LW.: Human papillomavirus typing in patients with Papanicolaou smears showing squamous atypia. Gynecol Oncol 1993;48:384-388.
42. Fait G, Daniel Y, Kupferminc MJ, Lessing JB, Niv J, Bar-Am A.: Does typing of human papillomavirus assist in the triage of women with repeated low-grade cervical cytologic abnormalities? Gynecol Oncol 1998;70:319-322.
43. Fait G, Daniel Y, Kupferminc MJ, Geva E, Ron IG, Lessing JB, Niv J, Bar-Am A.: Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal Pap smears before colposcopy referral. Gynecol Oncol 2000;79:177-180.
44. Lin CT, Tseng CJ, Lai CH, Hsueh S, Huang HJ, Lay KS.: High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or = 50 years of age. J Reprod Med 2000;45:345-350.
45. Morin C, Bairati I, Bouchard C, Fortier M, Roy M, Moore L.: Managing atypical squamous cells of undetermined significance in Papanicolaou smears. J Reprod Med 2001;46:799-805.
46. Rebello G, Hallam N, Smart G, Farquharson D, McCafferty J.: Human papillomavirus testing and the management of women with mildly abnormal cervical smears: an observational study. BMJ 2001;322:893-894.
47. Zielinski DJ, Rozendaal L, Voorhorst FJ, Runsink AP, de Schipper FA, Meijer CJ.: High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance. J Pathol 2001;195:300-306.
48. Hughes AA, Glazner J, Barton P, Shlay JC.: A cost-effectiveness analysis of four management strategies in the determination and follow-up of women with atypical squamous cells of undetermined significance. Diagn Cytopathol 2005;32:125-132.
49. Kim JJ, Wright TC, Goldie SJ.: Cost effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382-2390.
50. Simsir A, Ioffe O, Sun P, Elgert P, Cangiarella J, Levine PH.: Effect of Bethesda 2001 on reporting of atypical squamous cells (ASC) with special emphasis on atypical squamous cells-cannot rule out high grade (ASC-H). Diagn Cytopathol 2006;34:62-66.
51. Saad R, Kanborr A, Mauser N, Modery J, Dauds DJ.: Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H): diagnostic reproducibility, HPV positivity rates, and clinicial implications (abstract). Mod Pathol 2005;18:68A.
52. Lyman AK, Giampoli EJ, Bonfiglio TA.: Should women with atypical squamous cells, cannot exclude high grade squamous intraepithelial lesion receive reflex human papillomavirus HPV testing? Cancer 2005;105:457-460.
53. Shidham VB, Rao RN, Macchi J, Chavan A.: Microglandular hyperplasia has a cytomorphological spectrum overlapping with atypical squamous cells-cannot rule out high grade squamous intraepithelial lesion (ASC-H). Diagn Cytopathol 2004;30:57-61.
54. Rowe LR, Aldeen W, Benz JS.: Prevalence and typing of high risk HPV DNA by Hybrid Capture II in women with ASCUS, ASC-H, LSIL and AGC in ThinPrep Pap tests. Diagn Cytopathol 2004;30:426-432.
55. Prince TE, Dabbs D, Guido R.: The ASC-H dilemma: a new role for human papillomavirus testing (abstract). Obstet Gynecol 2005;105:3S.
56. Solomon D, Schiffman MH.: Have we resolved how to triage equivocal cytology? J Natl Cancer Inst 2004;96:250-251.
57. Wu HH, Allan SL, Kirkpatrick J, Elsheik TM..: High risk HPV DNA testing by HC II is a useful triage method for women with ASC-H on ThinPrep Pap tests (abstract). Mod Pathol 2005;18: 80A.
58. Srodon M, Dilworth HP, Ronnett RM.: Atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion (ASC-H): HPV testing and histologic results (abstract). Mod Pathol 2005:18:78A.
59. Hoschar A, Kink I, Dawson AE.: Atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion (ASC-H): correlation of morphologic features, reflex HPV DNA testing and biopsy follow-up. Acta Cytol 2004;48:271-272.
60. Moscicki AB, Shiboski S, Hills NK, Powell KJ, Jay N, Hanson EN, Miller S, Canjura-Clayton KL, Farhat S, Broering JM, Darragh TM.: Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 2004;364:1678-1683.
61. Cox JT.: Management of atypical squamous cells of undetermined significance and low-grade squamous intra-epithelial lesion by human papillomavirus testing. Best Pract Res Clin Obstet Gynaecol 2001;15:715-741.
62. Cox JT, Massad LS, Lonky N, Tosh R, Waxman A, Wilkinson E.: ASSCP Practice Guideline: management guidelines for follow-up of low grade squamous intraepithelial lesion (LSIL). J Low Gen Tract Dis 2000;4:83-92.
63. Acs G, Gupta PK, Baloch ZW.: Glandular and squamous atypia and intraepithelial lesions in atrophic cervicovaginal smears. One institution's experience. Acta Cytol 2000;44:611-617.
64. Kaufman RH, Adam E, Icenogle J, Reeves WC.: Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1997;176:87-92.
65. Giles JA, Deery A, Crow J, Walker P.: The accuracy of repeat cytology in women with mildly dyskaryotic smears. Brit J Obstet Gynecol 1989;96:1067-1070.
66. Ferris DF, Cox JT, O'Connor D, Wright C, Foerster J.: Modern Colposcopy. Dubuque, Kendall-Hunt, 2004, pp 525-578.
67. Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ, American Society for Colposcopy and Cervical Pathology: 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003;189:295-304.
68. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C, American Cancer Society: American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-362.
69. ACOG Practice Bulletin. Cervical Cytology Screening. Washington, American College of Obstetricians and Gynecologists, 2003.